Print PDF

Sheppard Mullin Continues Private Equity Team Expansion with Partner Michael Wilson

Wilson is the Fourth Transactional Partner to Join Chicago Office in 2024

Sheppard, Mullin, Richter & Hampton LLP is pleased to announce that Michael Wilson has joined the firm as a partner in the Corporate practice group. Based in the Chicago office, Wilson is a highly regarded corporate transactional lawyer representing a variety of private equity and venture capital funds, particularly in the healthcare, technology and renewable energy industries. He joins from Locke Lord where he was co-chair of the Corporate and Transactional Department and led the Venture Capital & Emerging Companies Section of the firm’s Private Equity & Venture Capital practice group.

Wilson handles mergers and acquisitions, debt finance transactions, venture capital transactions and general corporate matters for private equity funds and venture capital funds, startups and entrepreneurs, banks and non-bank lenders, and other public and private businesses. He has significant private equity experience, including with small business investment companies (SBICs), representing funds and limited partners in portfolio investments, limited partner investments, fund formation and SBIC licensing.

“Mike represents an impressive roster of funds across key sectors,” said Luca Salvi, chair of Sheppard Mullin. “Corporate, private equity, healthcare and renewable energy are areas we are intentionally growing, and Mike’s practice mix and expertise align with our strategic direction. We see great opportunity for our clients and his clients, and we are excited that he is now a member of our firm and team.”

Wilson has led clients through numerous, complex transactions, including:

  • Represented Chicago Pacific Founders as lead investor in a $90 Million PIPE offering by P3 Health Partners
  • Represented Prospect Partners in its investment in affiliated companies Fontanesi & Kann and Architectural Building Components
  • Represented Rapid Genomics in its acquisition by LGC Biosearch Technologies
  • Represented VIX, Inc. in its acquisition by Univision

“Mike is the fourth top-tier transactional partner we have attracted this year,” said Jeralin Cardoso, co-leader of the firm’s Corporate practice. “As we continue to expand our corporate, private equity and tax capabilities coast to coast, Mike adds even more strength to our seasoned bench. We are pleased to bring him on board.”

Recent transactions led by Sheppard Mullin’s private equity and healthcare teams include representing the selling group, led by Off Road Capital Partners, in the sale of one of Los Angeles’ most famous attractions, Pacific Park on the Santa Monica Pier, to SC Holdings; leading VillageMD through its $8.9 billion merger with Summit Health-CityMD, which was awarded M&A Deal of the Year by both PE Hub and Global M&A Network; advising Arlington Capital Partners in the sale of Octo to IBM for $1.2 billion; and leading Corbel Capital Partners in its investment in Premier Plastic Surgery Partners, creating the nation’s first-ever platform for plastic and facial plastic surgeons, which was awarded “Private Equity Deal of the Year” by Global M&A Network.

Wilson received his B.S., summa cum laude, from the University of Arizona and his J.D., magna cum laude, from the University of Illinois College of Law.

About Sheppard Mullin’s Corporate and Securities Practice Group
One of the firm's core strengths, Sheppard Mullin’s Corporate and Securities practice group, assists clients throughout the United States and abroad in maximizing their business opportunities. We represent clients that range from private to public companies and from startups and emerging businesses to international corporations. We are proud to offer CRADLE TO LIQUIDITY® services. We provide general business legal advice, assist in structuring and implementing major transactions, prepare agreements to address unique business arrangements, and consult with clients to resolve major business and ownership issues. We handle such matters as initial and later-stage venture and other financings; leveraged buyouts and recapitalizations; public offerings; mergers and acquisitions; SEC compliance; private equity transactions; real estate capital markets transactions; corporate, LLC and partnership formation; and corporate partnering, joint venture and other strategic alliance arrangements. Because of our diverse client base, we have experience representing substantial entities in complicated multinational and multistate transactions, as well as advising smaller and emerging clients on the full spectrum of business matters.

About Sheppard Mullin’s Healthcare Team
Sheppard Mullin’s 200+ attorney, full service, diverse, national healthcare industry team has been named a Health Care Practice Group of the Year by Law360 three times in seven years. Working in all sectors of healthcare nationally with industry-leading and growing companies, disruptive start-up clients and healthcare-focused investors, Sheppard Mullin is known for innovative transactions and joint ventures, regulatory solutions, population health management, global risk and value-based contracting, technology transactions/privacy and a full-service team offering significant experience in cybersecurity, tax, non-profit, employment and labor, real estate, artificial intelligence, antitrust, litigation and finance.


Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.